TECX: Tectonic Therapeutic Kompaniya qiymatining sof foydaga nisbati

Tectonic Therapeutic (TECX) korporativ emblemasi va logotipi

Tectonic Therapeutic, Inc. (TECX) turli patologiyalarga qarshi kurashish uchun yuqori aniqlikdagi platformalarni ishlab chiqayotgan yetakchi olimlar tomonidan boshqariladi. Biznes modeli iqtisodiy sikllar yoki mavsumiylikdan mustaqil bo'lib, tashqi zarbalarga chidamlilikni namoyish etadi. Operatsion faoliyat intellektual mulkka to'liq nazoratni saqlagan holda, uchinchi tomon laboratoriyalari bilan hamkorlik qilishga asoslangan. Joriy aksiya narxlarining ushbu grafigi -4.90 miqdoridagi PE koeffitsiyentini aks ettiradi.

TECX Tectonic Therapeutic Inc.: Narx-foyda koeffitsiyenti 22.06.2024 - 16.11.2026 oraligʻida

Tectonic Therapeutic Inc. (TECX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning har tomonlama tahlili:Tectonic - TECX
Tectonic Therapeutic yetakchi tovari

Tectonic Therapeutic, Inc. (TECX) uchun sun'iy intellektning molekulyar dizaynga integratsiyasi samaradorligi kelajakdagi kapitalizatsiyaga bevosita ta'sir ko'rsatadi. P/E koeffitsiyenti bitta aksiyaning bozor qiymatini sof foydaga nisbatan o'lchaydi va investitsiyalarning qoplanish muddatini belgilaydi. Kompaniyaning tarixiy P/E grafigini tahlil qilish orqali klinik sinovlar davrida fundamental ko'rsatkichlardan baholashdagi chetga chiqishlarni aniqlash mumkin. Ushbu metrikani sanoat o'rtachasi bilan solishtirish haddan tashqari ko'p to'lov qilish xavfini o'sish potentsiali bilan muvozanatga keltirish imkonini beradi.

Raqobatdosh kompaniyalar

HLN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti KVUE (Kenvue Corp)|VRNA (Verona Pharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Jyong Biotech Limited MENS|Ligand (LGND) - Kapitalizatsiyaning foydaga nisbati|AMRX: Narx-foyda koeffitsiyenti|Perrigo - Bozor narxining sof foydaga nisbati|ALVO: P/E multiplikatori|Liquidia Technologies - Kompaniya qiymatining sof foydaga nisbati|GLPG (Galapagos N.V.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati anipharmaceuticals.com ANIP|Narxning foydaga nisbati MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Pacira BioSciences, Inc. PCRX|P/E multiplikatori ARS Corp SPRY|Theravance Biopharma - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Narxning foydaga nisbati|Narx-foyda multiplikatori TNXP|Narxning foydaga nisbati China SXT Pharmaceuticals, Inc.|EPRX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori BHST|EXOZ - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ORMP (oramed.com)|P/E multiplikatori enterabio.com ENTX|HYFT - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati ABVC BioPharma, Inc ABVC|CPIX: P/E multiplikatori|Quantum BioPharma Ltd - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti FGEN|Telomir Pharmaceuticals, Inc. - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori RANI|SNYR (Synergy CHC) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Rallybio RLYB|Lexaria Bioscience (LEXX) - Kapitalizatsiyaning foydaga nisbati|PULM - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pheton Holdings PTHL|APM (Aptorum) - Narx-foyda koeffitsiyenti|Lyra Therapeutics, Inc. (LYRA) - P/E multiplikatori|IBO (impactbiomedinc.com) - P/E multiplikatori|TNFA (TNF Pharmaceuticals) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati cbdmd.com (YCBD)|Biznesning o‘zini qoplash muddati PainReform Ltd|P/E multiplikatori CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Kapitalizatsiyaning foydaga nisbati|OPTN - Narxning foydaga nisbati|Pieris Pharmaceuticals - Bozor narxining sof foydaga nisbati|PROC (Procaps Group) - Narx-foyda koeffitsiyenti|PTPI - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Qilian International Holding Group Limited|SLRN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TFFP (TFF Pharma)